These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1271 related articles for article (PubMed ID: 33837377)

  • 1. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
    Gaziano L; Giambartolomei C; Pereira AC; Gaulton A; Posner DC; Swanson SA; Ho YL; Iyengar SK; Kosik NM; Vujkovic M; Gagnon DR; Bento AP; Barrio-Hernandez I; Rönnblom L; Hagberg N; Lundtoft C; Langenberg C; Pietzner M; Valentine D; Gustincich S; Tartaglia GG; Allara E; Surendran P; Burgess S; Zhao JH; Peters JE; Prins BP; Angelantonio ED; Devineni P; Shi Y; Lynch KE; DuVall SL; Garcon H; Thomann LO; Zhou JJ; Gorman BR; Huffman JE; O'Donnell CJ; Tsao PS; Beckham JC; Pyarajan S; Muralidhar S; Huang GD; Ramoni R; Beltrao P; Danesh J; Hung AM; Chang KM; Sun YV; Joseph J; Leach AR; Edwards TL; Cho K; Gaziano JM; Butterworth AS; Casas JP;
    Nat Med; 2021 Apr; 27(4):668-676. PubMed ID: 33837377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19.
    Ma Y; Huang Y; Zhao S; Yao Y; Zhang Y; Qu J; Wu N; Su J
    Hum Mol Genet; 2021 Jun; 30(13):1247-1258. PubMed ID: 33949668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendelian Randomization Identifies Genetically Supported Drug Targets for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Zhu Y; Li M; Wang H; Yang F; Du R; Pang X; Bai J; Huang X
    Mol Neurobiol; 2024 Jul; 61(7):3809-3818. PubMed ID: 38019415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
    Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
    BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Landscape of the ACE2 Coronavirus Receptor.
    Yang Z; Macdonald-Dunlop E; Chen J; Zhai R; Li T; Richmond A; Klarić L; Pirastu N; Ning Z; Zheng C; Wang Y; Huang T; He Y; Guo H; Ying K; Gustafsson S; Prins B; Ramisch A; Dermitzakis ET; Png G; Eriksson N; Haessler J; Hu X; Zanetti D; Boutin T; Hwang SJ; Wheeler E; Pietzner M; Raffield LM; Kalnapenkis A; Peters JE; Viñuela A; Gilly A; Elmståhl S; Dedoussis G; Petrie JR; Polašek O; Folkersen L; Chen Y; Yao C; Võsa U; Pairo-Castineira E; Clohisey S; Bretherick AD; Rawlik K; ; ; Esko T; Enroth S; Johansson Å; Gyllensten U; Langenberg C; Levy D; Hayward C; Assimes TL; Kooperberg C; Manichaikul AW; Siegbahn A; Wallentin L; Lind L; Zeggini E; Schwenk JM; Butterworth AS; Michaëlsson K; Pawitan Y; Joshi PK; Baillie JK; Mälarstig A; Reiner AP; Wilson JF; Shen X
    Circulation; 2022 May; 145(18):1398-1411. PubMed ID: 35387486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome-wide summary data-based Mendelian randomization analysis reveals 38 novel genes associated with severe COVID-19.
    Krishnamoorthy S; Li GH; Cheung CL
    J Med Virol; 2023 Jan; 95(1):e28162. PubMed ID: 36127160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
    Liu D; Yang J; Feng B; Lu W; Zhao C; Li L
    J Infect; 2021 Jan; 82(1):126-132. PubMed ID: 33259846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation.
    Au Yeung SL; Wong THT; He B; Luo S; Kwok KO
    J Med Virol; 2023 Jan; 95(1):e28205. PubMed ID: 36217700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.
    Rao S; Lau A; So HC
    Diabetes Care; 2020 Jul; 43(7):1416-1426. PubMed ID: 32430459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
    Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
    Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
    Butler-Laporte G; Nakanishi T; Mooser V; Renieri A; Amitrano S; Zhou S; Chen Y; Forgetta V; Richards JB
    Int J Epidemiol; 2021 Mar; 50(1):75-86. PubMed ID: 33349849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
    Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
    Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared genetics and causal association between plasma levels of SARS-CoV-2 entry receptor ACE2 and Alzheimer's disease.
    Zhang Y; Xu F; Wang T; Han Z; Shang H; Han K; Zhu P; Gao S; Wang X; Xue Y; Huang C; Chen Y; Liu G
    CNS Neurosci Ther; 2024 Jul; 30(7):e14873. PubMed ID: 39056224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.
    Li X; Shen A; Zhao Y; Xia J
    Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
    Duan QQ; Wang H; Su WM; Gu XJ; Shen XF; Jiang Z; Ren YL; Cao B; Li GB; Wang Y; Chen YP
    BMC Med; 2024 Mar; 22(1):96. PubMed ID: 38443977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses.
    Zhang N; Li Y; Sundquist J; Sundquist K; Ji J
    EBioMedicine; 2023 Dec; 98():104859. PubMed ID: 38251461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mechanisms of critical illness in COVID-19.
    Pairo-Castineira E; Clohisey S; Klaric L; Bretherick AD; Rawlik K; Pasko D; Walker S; Parkinson N; Fourman MH; Russell CD; Furniss J; Richmond A; Gountouna E; Wrobel N; Harrison D; Wang B; Wu Y; Meynert A; Griffiths F; Oosthuyzen W; Kousathanas A; Moutsianas L; Yang Z; Zhai R; Zheng C; Grimes G; Beale R; Millar J; Shih B; Keating S; Zechner M; Haley C; Porteous DJ; Hayward C; Yang J; Knight J; Summers C; Shankar-Hari M; Klenerman P; Turtle L; Ho A; Moore SC; Hinds C; Horby P; Nichol A; Maslove D; Ling L; McAuley D; Montgomery H; Walsh T; Pereira AC; Renieri A; ; ; ; ; ; ; Shen X; Ponting CP; Fawkes A; Tenesa A; Caulfield M; Scott R; Rowan K; Murphy L; Openshaw PJM; Semple MG; Law A; Vitart V; Wilson JF; Baillie JK
    Nature; 2021 Mar; 591(7848):92-98. PubMed ID: 33307546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.